RedHill Biopharma reported $12.56M in Current Assets for its fiscal quarter ending in June of 2025.





Current Assets Change Date
Clal Biotechnology ILS 14.69M 1.95M Dec/2023
Compugen USD 88.92M 8.72M Sep/2025
Cronos Group USD 922.15M 5M Sep/2025
RedHill Biopharma USD 12.56M 644K Jun/2025